Gilbert Arizaga, MD
Dermatology Physician in Silver City, New Mexico.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 15,011 in Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Gilbert Arizaga, MD carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 1,243 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 1K
- Part D claims, 2024
- 96%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Gilbert Arizaga, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1770530867), first enumerated 05/27/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,243 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1770530867 · Dermatology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-NEUTRAL · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1770530867
- ENUM-LEGACY 2006
- TAX-MID 15K Dermatology Physician
- MIPS-NEUTRAL 75/100
- RX-MID 1,243
- BOOK-THIN 54 in New Mexico
- PHOTO-ENUM Theresa Behrs · 2006
Gilbert Arizaga, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,243 ≥ 78th percentile 78% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
Gilbert Arizaga, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Gilbert Arizaga, MD?
CMS neutral score, not measuredPrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Mexico
How Dermatology Physician compares to other specialties among New Mexico providers
Dermatology Physician ranks #96 among New Mexico's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the New Mexico provider total, by primary NUCC taxonomy. The highlighted bar is Dermatology Physician; the long tail of smaller specialties is omitted for legibility.
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1770530867 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/27/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Gilbert Arizaga, MD's current license status, disciplinary history, and board certifications with the New Mexico Medical Board in New Mexico before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1770530867 is the unique 10-digit identifier CMS uses to link Arizaga across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Brand vs generic prescribing mix · Generic-heavy
4% brand-name claims vs 96% generic, on 1,243 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 1,454.233
- Total Day Supply
- 37,741
- Brand vs Generic
- 4% brand / 96% generic
- Brand Drug Cost
- $199K
- Generic Drug Cost
- $42K
- Antibiotic Claims
- 117
Patient Demographics
- Average Patient Age
- 74.5 years
- Avg HCC Risk Score
- 1.11
- Gender Split
- 45% female / 55% male
- Age Distribution
- <65: 30, 65-74: 145, 75-84: 158, 85+: 45
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Gilbert Arizaga, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Triamcinolone Acet…
Triamcinolone Acetonide
311 claims
- Imiquimod 93
Imiquimod
93 claims
- Clobetasol Propion… 76
Clobetasol Propionate
76 claims
- Doxycycline Monohy… 58
Doxycycline Monohydrate
58 claims
- Clobetasol Emollient 51
Clobetasol Emollient
51 claims
- Ketoconazole 49
Ketoconazole
49 claims
- Mupirocin 44
Mupirocin
44 claims
- Mometasone Furoate 42
Mometasone Furoate
42 claims
| Drug | Claims |
|---|---|
| Triamcinolone Acetonide | 311 |
| Imiquimod | 93 |
| Clobetasol Propionate | 76 |
| Doxycycline Monohydrate | 58 |
| Clobetasol Emollient Clobetasol Propionate/Emoll | 51 |
| Ketoconazole | 49 |
| Mupirocin | 44 |
| Mometasone Furoate | 42 |
| Cefuroxime Cefuroxime Axetil | 40 |
| Gabapentin | 35 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How Gilbert Arizaga, MD fits within the Dermatology Physician landscape nationally.
Gilbert Arizaga, MD's 1,243 claims are above the specialty average of 799.
Nationwide Dermatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Arizaga, both outside New Mexico so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Dermatology Physician Providers in New Mexico
Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as Arizaga.
One of 54 Dermatology Physician providers enrolled in New Mexico, 5 are shown here.
Compare Dermatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Gilbert Arizaga, MD's specialty? ▼
How much does Gilbert Arizaga, MD prescribe under Medicare Part D? ▼
What is Gilbert Arizaga, MD's Medicare quality score? ▼
Where is Gilbert Arizaga, MD located? ▼
What is Gilbert Arizaga, MD's NPI number? ▼
Does Gilbert Arizaga, MD prescribe more brand-name or generic drugs? ▼
How many Dermatology Physician providers are there in the US? ▼
What drugs does Gilbert Arizaga, MD prescribe most often? ▼
Does Gilbert Arizaga, MD accept Medicare? ▼
How can I verify Gilbert Arizaga, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.